These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24629333)

  • 1. Viruses for tumor therapy.
    Bell J; McFadden G
    Cell Host Microbe; 2014 Mar; 15(3):260-5. PubMed ID: 24629333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes.
    Malogolovkin A; Gasanov N; Egorov A; Weener M; Ivanov R; Karabelsky A
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viruses for cancer immunotherapy.
    Hemminki O; Dos Santos JM; Hemminki A
    J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic viruses in the treatment of cancer: a review of current strategies.
    Zeyaullah M; Patro M; Ahmad I; Ibraheem K; Sultan P; Nehal M; Ali A
    Pathol Oncol Res; 2012 Oct; 18(4):771-81. PubMed ID: 22714538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model of oncolytic virotherapy with time delay.
    Wang ZZ; Guo ZM; Smith H
    Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent clinical experience with oncolytic viruses.
    Donnelly OG; Errington-Mais F; Prestwich R; Harrington K; Pandha H; Vile R; Melcher AA
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1834-41. PubMed ID: 21740364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
    Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
    Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic Virotherapy: An Advanced Microbial Approach for the Management of Cancer.
    Rao MFS; Ahmed B; Qadir MI
    Crit Rev Eukaryot Gene Expr; 2024; 34(1):1-13. PubMed ID: 37824388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Going viral: a review of replication-selective oncolytic adenoviruses.
    Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
    Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current strategies of virotherapy in clinical trials for cancer treatment.
    Lin W; Zhao Y; Zhong L
    J Med Virol; 2021 Aug; 93(8):4668-4692. PubMed ID: 33738818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.
    Rajani KR; Vile RG
    Viruses; 2015 Nov; 7(11):5889-901. PubMed ID: 26580645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on… Gabriella Campadelli-Fiume.
    Campadelli-Fiume G
    FEMS Microbiol Lett; 2018 Jun; 365(11):. PubMed ID: 29873707
    [No Abstract]   [Full Text] [Related]  

  • 16. Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.
    Kaur B; Chiocca EA; Cripe TP
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1842-51. PubMed ID: 21740359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction of telomerase-specific oncolytic virotherapy and chemotherapeutic agents for human cancer.
    Fujiwara T; Kagawa S; Tazawa H
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1809-16. PubMed ID: 21740362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer gene therapy with oncolytic adenoviruses.
    Guse K; Hemminki A
    J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of virotherapy and T-cell therapy: arming oncolytic virus with T-cell engagers.
    Song XT
    Discov Med; 2013 Dec; 16(90):261-6. PubMed ID: 24333405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones.
    Martin NT; Bell JC
    Mol Ther; 2018 Jun; 26(6):1414-1422. PubMed ID: 29703699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.